These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders. Sacco KA, Notarangelo LD, Delmonte OM. Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991 [Abstract] [Full Text] [Related]
4. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants. Ishimura M, Eguchi K, Shiraishi A, Sonoda M, Azuma Y, Yamamoto H, Imadome KI, Ohga S. Front Pediatr; 2019 Apr; 7():183. PubMed ID: 31231620 [Abstract] [Full Text] [Related]
5. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases. Parvaneh N, Filipovich AH, Borkhardt A. Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097 [Abstract] [Full Text] [Related]
8. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host. Worth AJ, Houldcroft CJ, Booth C. Br J Haematol; 2016 Nov; 175(4):559-576. PubMed ID: 27748521 [Abstract] [Full Text] [Related]
9. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. Abolhassani H, Edwards ES, Ikinciogullari A, Jing H, Borte S, Buggert M, Du L, Matsuda-Lennikov M, Romano R, Caridha R, Bade S, Zhang Y, Frederiksen J, Fang M, Bal SK, Haskologlu S, Dogu F, Tacyildiz N, Matthews HF, McElwee JJ, Gostick E, Price DA, Palendira U, Aghamohammadi A, Boisson B, Rezaei N, Karlsson AC, Lenardo MJ, Casanova JL, Hammarström L, Tangye SG, Su HC, Pan-Hammarström Q. J Exp Med; 2017 Jan; 214(1):91-106. PubMed ID: 28011864 [Abstract] [Full Text] [Related]
10. Genetic susceptibility to EBV infection: insights from inborn errors of immunity. Tangye SG. Hum Genet; 2020 Jun; 139(6-7):885-901. PubMed ID: 32152698 [Abstract] [Full Text] [Related]
15. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. Edwards ESJ, Bier J, Cole TS, Wong M, Hsu P, Berglund LJ, Boztug K, Lau A, Gostick E, Price DA, O'Sullivan M, Meyts I, Choo S, Gray P, Holland SM, Deenick EK, Uzel G, Tangye SG. J Allergy Clin Immunol; 2019 Jan; 143(1):276-291.e6. PubMed ID: 29800648 [Abstract] [Full Text] [Related]
17. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W. Proc Natl Acad Sci U S A; 2016 Oct 18; 113(42):E6467-E6475. PubMed ID: 27698133 [Abstract] [Full Text] [Related]